Publications by authors named "Barry Johnson"

Claim this Profile
P
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers.
Jibran Ahmed, Geraldine O'Sullivan Coyne, Larry V Rubinstein, Sarah J Shin, Naoko Takebe, Barry C Johnson

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors.
Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar, Sarah B Miller, Barry C Johnson

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas.
Geraldine O'Sullivan Coyne, Shivaani Kummar, Larry V Rubinstein, Deborah Wilsker, Nancy Moore, Barry C Johnson

Cancer Chemother Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G Herrick, Barry C Johnson

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROADMAPS: An Online Database of Response Data, Dosing Regimens, and Toxicities of Approved Oncology Drugs as Single Agents to Guide Preclinical In Vivo Studies.
Melinda G Hollingshead, Nathaniel Greenberg, Michelle Gottholm-Ahalt, Richard Camalier, Barry C Johnson

Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.
Shivaani Kummar, Apurva K Srivastava, Tony Navas, Fabiola Cecchi, Young H Lee, Barry C Johnson

Invest New Drugs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Animal Health Trust (1942-2020).
Andrew J Higgins, Keith C Meldrum, J Barry Johnson, Peter M Biggs, Edward A Chandler

Vet J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflecting on the closure of the Animal Health Trust.
Andrew Higgins, Keith Meldrum, Barry Johnson, Peter Biggs, Edward Chandler

Vet Rec· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies.
William G Herrick, Casey L Kilpatrick, Melinda G Hollingshead, Dominic Esposito, Geraldine O'Sullivan Coyne, Barry C Johnson

Mol Cancer Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors.
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, Jerry Collins, Joel M Reid, Barry C Johnson

Oncotarget· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Call Bell Usage: Tracking the Effect of Hourly Staff Rounding.
Barry C Johnson, Laurie Bryant

Clin J Oncol Nurs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard of proof at RCVS disciplinary hearings.
Richard Stephenson, Jacqui Molyneux, Barry Johnson, Mark Elliott, Beverley Cottrell

Vet Rec· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seidel aberration coefficients: an alternative computational method.
Psang Dain Lin, R Barry Johnson

Opt Express· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.
Kevin M Peese, Christopher W Allard, Timothy Connolly, Barry L Johnson, Chen Li

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of derivative matrices of skew rays to direct and inverse problems of Risley and tilting orthogonal double-prism systems.
Psang Dain Lin, R Barry Johnson

J Opt Soc Am A Opt Image Sci Vis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.
Mathieu Métifiot, Barry C Johnson, Evgeny Kiselev, Laura Marler, Xue Zhi Zhao

Nucleic Acids Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.
Xue Zhi Zhao, Steven J Smith, Mathieu Métifiot, Barry C Johnson, Christophe Marchand

J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the within- and between-lot variability of Whatman™ FTA(®) DMPK and 903(®) DBS papers and their suitability for the quantitative bioanalysis of small molecules.
Jacquelynn Luckwell, Philip Denniff, Stephen Capper, Paul Michael, Neil Spooner, Barry Johnson

Bioanalysis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homology model of HIV-1 integrase and analysis of mutations designed to test the model.
Barry C Johnson, Mathieu Métifiot, Andrea Ferris, Yves Pommier, Stephen H Hughes

J Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase.
Mathieu Métifiot, Kasthuraiah Maddali, Barry C Johnson, Stephen Hare, Steven J Smith

ACS Chem Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.
Xue Zhi Zhao, Kasthuraiah Maddali, Steven J Smith, Mathieu Métifiot, Barry C Johnson

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.
Barry C Johnson, Gary T Pauly, Ganesha Rai, Disha Patel, Joseph D Bauman

Retrovirology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy.
A Lee Dellon, Vickie L Muse, D Scott Nickerson, Thomas Akre, Sharon R Anderson, J Barry Johnson

J Reconstr Microsurg· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A positive Tinel sign as predictor of pain relief or sensory recovery after decompression of chronic tibial nerve compression in patients with diabetic neuropathy.
A Lee Dellon, Vicki L Muse, Nickerson D Scott, Thomas Akre, Sharon R Anderson, J Barry Johnson

J Reconstr Microsurg· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.
Suhman Chung, Jennifer T Miller, Barry C Johnson, Stephen H Hughes, Stuart F J Le Grice

J Biol Chem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis